|1.||Torchilin, Vladimir P: 9 articles (12/2014 - 10/2002)|
|2.||Bakovic, Marica: 3 articles (11/2015 - 04/2012)|
|3.||Zhu, Lin: 3 articles (03/2014 - 04/2012)|
|4.||Sawant, Rupa R: 3 articles (02/2014 - 01/2010)|
|5.||Simões, Cláudia: 3 articles (07/2013 - 07/2010)|
|6.||Domingues, Pedro: 3 articles (07/2013 - 07/2010)|
|7.||Miyazawa, Teruo: 3 articles (07/2012 - 08/2010)|
|8.||Nakagawa, Kiyotaka: 3 articles (07/2012 - 08/2010)|
|9.||Shoji, Naoki: 3 articles (07/2012 - 08/2010)|
|10.||Sanmarco, M: 3 articles (09/2009 - 05/2001)|
06/15/2014 - "Here we hypothesized that the uptake of DHA by tumor cells is related to the phosphatidylethanolamine (PE) contents in cell membranes. "
04/01/2011 - "Because the distribution of phosphatidylethanolamine (PE) and PS within the membrane is coregulated, we reasoned that PE would also be localized in the outer membrane leaflet of tumor EC. "
04/01/2011 - "Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium."
06/01/2001 - "In both tumor types, the amounts of both phosphatidylethanolamine and sphingomyelin exceed the control values. "
09/01/1988 - "The nonresponsive tumor cells are able to synthesize the necessary amount of phosphatidylethanolamine to sustain growth. "
03/01/2013 - "Animal studies suggest that the hepatic ratio of phosphatidylcholine (PC) to phosphatidylethanolamine (PE) contributes to steatogenesis and inflammation. "
01/01/2013 - "However, recent studies demonstrate that phosphatidylethanolamine (PE) is a major target for these aldehydes, forming aldehyde-modified PEs (al-PEs) as a novel family of mediators for inflammation. "
08/07/2009 - "Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease."
08/12/2011 - "It conceivably uses heparin and phosphatidylcholine/phosphatidylethanolamine as anchors to increase protein localization and effective concentration at sites of injury, cell activation, or inflammation."
11/01/2009 - "The decrease of major cytoplasmic membrane phospholipids (phosphatidylcholine and phosphatidylethanolamine) content was established in mucosal epithelial cell under colon inflammation pathology--ulcerative colitis. "
01/01/1988 - "Pulse-chase studies were performed to investigate the metabolism of phosphatidylethanolamine (PEA) in cultured fibroblasts from patients with mucolipidosis type IV (MLIV) and normal controls. "
11/01/2007 - "Moreover, higher levels of PC in patients affected by sialidosis (3.6-fold) and Gaucher (4-fold) disease, and of PC (4.15-fold) and phosphatidylethanolamine (2.3-fold) in a patient affected by Sandhoff disease were noted. "
08/04/1993 - "In the present study, PK-C activity and PK-C-mediated phosphorylation of endogenous substrates were studied in skin fibroblasts from patients with mucolipidosis type 4 [ML-4], in which there is accumulation of the phospholipids phosphatidylcholine, lysophosphatidylcholine, phosphatidylethanolamine as well as gangliosides. "
02/01/1995 - "There follows, as ischemia progresses, loss of sarcolemmal bilayer stability due to the expression of the non-bilayer behavior of phosphatidylethanolamine, leading to irreversible disruption of the sarcolemma and cell death."
02/01/1995 - "In our view, onset of ischemia initiates a sequence of events leading to a loss of normal sarcolemmal phospholipid distribution with an outward migration of phosphatidylethanolamine. "
09/01/1993 - "Loss of asymmetric distribution of sarcolemmal phosphatidylethanolamine during simulated ischemia in the isolated neonatal rat cardiomyocyte."
01/01/2011 - "Retinal ischemia, induced in adult rats by increasing the intraocular pressure, was characterized by a reduction in the phosphatidylethanolamine-modified form of LC3 (LC3II) and by a significant decrease in Beclin-1. "
03/01/2002 - "Modification of the phospholipid fatty acid (FA) composition under ischemia-reperfusion didn't bear total character and was more manifested in cardiolipin (CL) and phosphatidylethanolamine (PE). "
|4.||dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamine
|1.||Fluid Therapy (Oral Rehydration Therapy)
|3.||Quantum Dots (Quantum Dot)